Many people who have a sedentary lifestyle or profession that requires sitting or standing for long periods face problems in their legs that often go unnoticed. Factors like poor circulation, improper footwear, and inadequate leg movement lead to leg-related issues such as discomfort, swelling, and even more serious conditions like venous disorders. Understanding this disconnect, Varco Leg Care set out to bridge this gap with its low-friction self-care technology that helps users look after their leg health.
Towards its mission as the world’s first dedicated leg care brand, New Delhi-based Varco Leg Care has secured an investment of US$ 0.5 million (over INR 4.5 crore) in a seed funding round led by Sunicon Maiden Fund, an early-stage venture fund under Sunicon Ventures. This funding has helped the company to double its valuation within 10 months.
Saloni Jain, Founding Partner, Sunicon Ventures said, “We are proud to back Varco Leg Care, India’s first digital-native consumer healthcare brand revolutionizing leg care. With a team boasting 30 years of research and a strong IP portfolio, Varco is set to transform diabetic foot and varicose vein treatment. We at Sunicon are excited to support Varco’s mission in reshaping healthcare accessibility and outcomes across India”.
With the funding, Varco Leg Care will increase its marketing efforts and its presence in physical stores, making it easier for more people to access their products and services. Varco Leg Care also aims to enhance its products and technology through further research. Additionally, the company aims to expand its intellectual property portfolio where it is planning to obtain more patents to protect its innovative ideas and products. Varco also plans to publish the results of their in-house clinical studies in prestigious medical journals, to add credibility.
Varco Leg Care was able to increase its revenue by 110% in the last year due to its new low-friction self-care technology which enables users to actively self-diagnose their leg health while enhancing personalized recommendations and improving treatment adherence for consumers.
Varco Leg Care has successfully earned the trust of consumers across India and the world with its 42% customer retention rate. Since starting in 2022, they have helped over 500,000 people and are in 3000+ stores across cities like Mumbai and Delhi. Their products can also be seen in Walmart USA and popular stores in India like Guardian Pharmacy. Additionally, they also sell online on their website and online marketplaces like Amazon and Flipkart.
Speaking about the latest fundraise, Anondeep Ganguly, CEO, of Varco Leg Care said, “We are elated to announce our seed fundraise led by Sunicon Maiden Fund, signifying their strong vote of confidence in Varco’s groundbreaking approach to leg health management. This capital infusion serves as a major milestone in our growth journey; it not just propels us in boosting our customer base, supply chain, and offline visibility, but will also be playing a pivotal role in advancing our steadfast commitment to presenting robust clinical evidence-based research and solutions. We are not only emphasizing and focusing on extensive clinical trials, but also leveraging a pioneering low-friction technology to establish and validate that evidence. Going ahead, as we grow and scale exponentially and remain committed to delivering superlative leg health solutions, we shall continue placing the needs of our valued customers at the heart of our R&D initiatives”.
Varco Leg Care: Addressing the Leg Health Landscape
Founded in 2022 by Anondeep Ganguly, Varco Leg Care is the world’s first health care brand, that is dedicated to leg health. Their core mission is to transform the landscape of leg health management through innovative digital solutions. By merging cutting-edge technology with clinical expertise, they aim to empower individuals to proactively manage their leg health, promoting early detection and self-care.
Anondeep Ganguly, CEO, of Varco Leg Care, said, “Our investors trust Varco’s commitment to healthier legs. We want to be the global leader in leg care.”
Varco has curated a comprehensive range of products that are designed to meet the various leg health needs of individuals worldwide. Their products are backed by scientific research and target common leg health concerns such as varicose veins, diabetic foot, foot ulcers, restless leg syndrome, and more.
The company recently launched the world’s first artificial intelligence-powered leg health test, which harnesses the power of AI and neural algorithms to offer users personalized options for addressing their specific leg health conditions.
The Idea Behind Varco Leg Care
Varco Leg Care started as an idea to make leg health easier for everyone. Anondeep Ganguly noticed many people in Mumbai were struggling with varicose veins, but there were not many simple solutions available. Varco began as an idea that was already in the lab.
After finishing his Business Administration degree from Oxford Brookes University, he wanted to create a brand that would make a real difference for people. He went out to talk to chemists and their customers and realized there were no easy solutions available for leg health care. So, using his father’s research on plant molecules, Anondeep created Varco to offer easy, natural ways to care for legs.
Anondeep’s father Dr. Ganguly had spent 40 years studying plant molecules and had come up with many innovative treatments and ways to diagnose pain. They started their journey with a physical pain management clinic. Then, in 2016-17, they began building Varco as a brand for everyone.
Today, Varco is all about providing accessible and effective solutions for leg health problems. By combining science and nature, Varco aims to make leg care simpler and more manageable for everyone.
Anondeep Ganguly, CEO and Founder of Varco Leg Care said, “Our research shows that 30% of Indians face leg issues with no correct product or solution helping them relieve or cure the pain. More so, this part of the body is always ignored with people trudging their way with pain. Our first-of-its-kind Leg Health Test represents a significant leap forward in personalised leg healthcare, where we provide users with ultra-targeted recommendations to address their unique needs, empowering them to take charge of their health journey. By incorporating Neural Network Technology, we aim to empower individuals to proactively improve their leg health and maintain it.”
Join The Story Watch’s initiative to create a vibrant community for the startup ecosystem.